 Organovo Holdings, Inc. Organovo Nasdaq: ONVO convened, on March 26, 2020, the special meeting of stockholders the Special Meeting and then adjourned the Special Meeting until Tuesday, April 7, 2020 10:00 A.M. Pacific Time at to solicit additional proxies for Organovo Proposals Nos. 1 and 4. Organovo Proposal No. 1 is to approve the issuance of shares of Organovo common stock to the Tarveda Therapeutics, Inc. Tarveda securityholders in the proposed merger and Organovo Proposal No. 4 is to approve the adoption of the Combined Organization 2020 Equity Incentive Plan. These proposals are described in more detail in the proxy statementprospectusinformation statement of Organovo dated February 24, 2020, furnished to Organovos stockholders in connection with the solicitation of proxies by the Organovo Board of Directors for use at the Special Meeting. On March 16, 2020, Organovo mailed a notice of change of location to stockholders of record, in compliance with Delaware law, regarding Organovo moving the Special Meeting to a virtual meeting format. 